FDA Import Refusal 1FX-7857164-3/20002/3 — SMARTWAY WELLNESS
The FDA refused shipment 1FX-7857164-3/20002/3 from SMARTWAY WELLNESS (India) on Oct 1, 2026. The refused product falls under Drugs and Biologics — GLIMEPIRIDE (ANTI-DIABETIC). Cited charge: 75
Refusal Details
- Date
- Oct 1, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY31 GLIMEPIRIDE (ANTI-DIABETIC)
- Charges
- 75